Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti-TNF-alpha-Results from a 12-year multicentric observational prospective study
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie
PubMed
38407515
DOI
10.1111/jdv.19916
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- hidradenitis suppurativa * farmakoterapie komplikace MeSH
- infliximab terapeutické užití MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory kůže farmakoterapie MeSH
- prospektivní studie MeSH
- spinocelulární karcinom * farmakoterapie MeSH
- TNF-alfa * antagonisté a inhibitory MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
- Názvy látek
- infliximab MeSH
- TNF-alfa * MeSH
Department of Dermatology and Venerology University Hospital Motol Prague Czech Republic
Department of Pharmacology 2nd Faculty of Medicine Charles University Prague Czech Republic
Zobrazit více v PubMed
Jourabchi N, Fischer AH, Cimino‐Mathews A, Waters KM, Okoye GA. Squamous cell carcinoma complicating a chronic lesion of hidradenitis suppurativa: a case report and review of the literature. Int Wound J. 2017;14:435–438.
Lavogiez C, Delaporte E, Darras‐Vercambre S, Martin De Lassale E, Castillo C, Mirabel X, et al. Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology. 2010;220:147–153.
Cooper SD, Cowdrey MCE, Linos KD, Lefferts JA, Basic KK. Squamous cell carcinoma in hidradenitis suppurativa lesions following tumor necrosis factor α inhibitors. Cutis. 2021;107:E5–E7.
Kreher MA, Konda S, Noland MMB, Longo MI, Valdes‐Rodriguez R. Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: methotrexate, alkylating agents, biologics, and small molecule inhibitors. J Am Acad Dermatol. 2023;88:534–542.
Li Pomi F, Macca L, Motolese A, Ingrasciotta Y, Berretta M, Guarneri C. Neoplastic implications in patients suffering from hidradenitis suppurativa under systemic treatments. Biomedicine. 2021;9:1594.
Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, et al. Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*. Br J Dermatol. 2021;184:133–140.
Ruggiero A, Lauro W, Miano C, Villani A, Fabbrocini G, Marasca C. Advanced squamous cell carcinoma developed on chronic hidradenitis suppurativa, successfully treated with cemiplimab: a case report. Case Rep Dermatol. 2023;15:35–39.
